- Report
- December 2023
- 80 Pages
China
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 80 Pages
South Korea
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 80 Pages
Saudi Arabia
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 80 Pages
India
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 80 Pages
Germany
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 80 Pages
France
From €663EUR$750USD£574GBP
€1327EUR$1,500USD£1,148GBP
- Report
- May 2023
- 100 Pages
Africa
From €885EUR$1,000USD£765GBP
€1769EUR$2,000USD£1,530GBP
- Report
- May 2023
- 255 Pages
Global
From €1106EUR$1,250USD£956GBP
€2212EUR$2,500USD£1,913GBP
- Clinical Trials
- July 2024
- 745 Pages
Global
From €3052EUR$3,450USD£2,639GBP
- Clinical Trials
- April 2024
- 390 Pages
Global
From €2212EUR$2,500USD£1,913GBP
- Report
- November 2022
- 103 Pages
Global
From €3494EUR$3,950USD£3,022GBP
- Report
- July 2024
- 19 Pages
Global
From €13265EUR$14,995USD£11,472GBP
- Newsletter
- September 2025
- 2 Pages
Global
From €116EUR$131USD£100GBP
- Report
- April 2025
- 71 Pages
China
From €1592EUR$1,800USD£1,377GBP
- Report
- April 2025
- 100 Pages
China
From €1592EUR$1,800USD£1,377GBP
- Report
- January 2025
- 24 Pages
India
From €995EUR$1,205USD£891GBP
- Report
- November 2024
- 25 Pages
Germany
From €995EUR$1,205USD£891GBP
- Report
- October 2024
- 25 Pages
Taiwan
From €995EUR$1,205USD£891GBP
- Report
- October 2024
- 24 Pages
Saudi Arabia
From €995EUR$1,205USD£891GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more